Pulmonary Arterial Hypertension Topic Center

Featured Article

Interview

Key Pharmaceutical Pipeline Developments: Insights from Industry Experts

05/29/2024

Leslie Fish, RPh, Senior Vice President of Clinical Pharmacy, IPD Analytics, LLC

Jeffrey Casberg, MS, RPh, IPD, Vice President of Clinical Pharmacy, IPD Analytics, LLC

Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.

Learn about promising drugs...

05/29/2024

First Report Managed Care

Interview

Improving Patient Engagement in Managed Care Pharmacy Through Collaboration

05/21/2024

Sarah Emond, MPP, President and Chief Executive Officer, ICER

Patient perspectives play a crucial role in shaping healthcare decisions, and AMCP 2024 session speaker Sarah Emond discusses the importance of patient engagement in drug value assessments within the managed care framework, providing examples...

Patient perspectives play a...

05/21/2024

First Report Managed Care

Conference Coverage

Specialty Pharmaceuticals Pipeline: Biologic and Biosimilar Approvals and Projected Developments

04/29/2024

Hannah Musick

Explore the latest trends and developments in the specialty pharmaceutical pipeline, including key legal matters, FDA issues, notable approvals, and potential biosimilar savings projected for the next decade as shared in a 2024 AMCP session.

Explore the latest trends and...

04/29/2024

First Report Managed Care

News

Budget Analysis of Addition of Riociguat for PAH and CTEPH

03/16/2015

Mary Beth Nierengarten

Results of a budgetary impact model study showed that the addition of riociguat to treat patients with PAH or CTEPH offers US health plans an additional treatment for these conditions that is safe, effective, and associated with minimal...

Results of a budgetary impact...

03/16/2015

First Report Managed Care

Conference Coverage

Federal Trade Commission’s Report Highlights PBMs’ Influence Over Drug Costs and Access in the US

09/17/2024

Grace Taylor , MS, MA;

In July 2024, the Federal Trade Commission (FTC) published an interim report discussing the impact that pharmacy benefit managers (PBMs) have on the accessibility and affordability of drugs in the US. The report was issued as part of an...

In July 2024, the Federal Trade...

09/17/2024

First Report Managed Care

News

Obesity Significantly Increases Cancer Risk in Patients With Cardiovascular Disease

09/16/2024

Lisa Kuhns , PhD, MD;

Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...

Obesity is associated with an...

09/16/2024

First Report Managed Care

News

CDC Invests $400 Million to Accelerate HIV Prevention and Surveillance Efforts Nationwide

09/16/2024

Lisa Kuhns , PhD, MD;

The Centers for Disease Control and Prevention (CDC) has awarded $400 million in funding to boost HIV prevention and surveillance efforts across the United States, aiming to accelerate progress in reducing new infections and improving health...

The Centers for Disease Control...

09/16/2024

First Report Managed Care

News

HHS Unveils Comprehensive Healthcare Reforms to Boost Equity and Quality

09/13/2024

Lisa Kuhns , PhD, MD;

The US Department of Health and Human Services (HHS) has announced updates to Medicare payments and policies to improve healthcare accessibility, equity, and quality for millions of Americans, according to a press release by the HHS.

The US Department of Health and...

09/13/2024

First Report Managed Care

Conference Coverage

SOHO 2024 Insights: Examining the Use and Cost of Interferon Therapy for MPNs

09/13/2024

Amber Denham ;

In this interview, a leading expert discusses myeloproliferative neoplasms, as presented at the SOHO annual conference. Explore the interview to gain key insights into interferon therapies and important considerations for payers regarding...

In this interview, a leading...

09/13/2024

First Report Managed Care

News

Challenges and Emerging Strategies in Overcoming Resistance in EGFR-Mutant NSCLC

09/10/2024

Lisa Kuhns , PhD, MD;

Despite promising early results, adding immunotherapy to standard chemotherapy does not significantly improve outcomes for patients with EGFR-mutant non-small cell lung cancer (NSCLC) who have progressed after initial targeted therapy,...

Despite promising early results,...

09/10/2024

First Report Managed Care

News

New 4F-PCC Proves Effective in Rapid Reversal of Anticoagulation for Urgent Surgery, Clinical Trial Finds

09/10/2024

Lisa Kuhns , PhD, MD;

An investigational 4-factor prothrombin complex concentrate (4F-PCC) is as effective and safe as an FDA-approved 4F-PCC for rapidly reversing vitamin K antagonist (VKA) anticoagulation in patients requiring urgent surgery, according to a...

An investigational 4-factor...

09/10/2024

First Report Managed Care

News

Obesity's Dual Role in Abdominal Aortic Aneurysm: Risk Factor and Protective Paradox

09/03/2024

Lisa Kuhns , PhD, MD;

Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...

Obesity, traditionally...

09/03/2024

First Report Managed Care

News

Stereotactic Magnetic Resonance (MR)-Guided Radiotherapy Shows Promise for Inoperable Upper Tract Urothelial Carcinoma

09/03/2024

Lisa Kuhns , PhD, MD;

Stereotactic MR-guided radiotherapy shows promise as an effective treatment for upper tract urothelial carcinoma (UTUC), particularly in patients who are not candidates for surgery, according to a case study presented in Frontiers in Oncology.

Stereotactic MR-guided...

09/03/2024

First Report Managed Care

Conference Coverage

Overcoming Challenges in Non-Cystic Fibrosis Bronchiectasis Research

08/29/2024

Hannah Musick ;

Research in non-cystic fibrosis bronchiectasis (NCFBE) is expanding, but collaboration is crucial to address challenges such as heterogeneity and limitations of single-center studies to advance understanding and treatment strategies for...

Research in non-cystic fibrosis...

08/29/2024

First Report Managed Care